August 21st, 2017
Diabetes patients taking Invokana and other medications containing the drug canagliflozin may face an increased risk of lower limb amputation, …
Tags: canagliflozin, foot amputation, Invokamet, Invokana, leg amputation, type 2 diabetes
Posted in HO&P Legal Blog, Invokana |
October 4th, 2016
Janssen Pharmaceuticals and Mitsubishi Tanabe Pharma are facing dozens of lawsuits filed by patients who suffered kidney damage or other …
Tags: canagliflozin, diabetes, diabetic ketoacidosis, Invokana, Janssen Pharmaceuticals, kidney damage, MDL, Mitsubishi Tanabe Pharma, SGLT2 inhibitors
Posted in HO&P Legal Blog, Pharmaceutical Liability |
June 8th, 2015
The Food and Drug Administration has issued a warning about a risk of life-threatening complications in patients taking a new …
Tags: diabetes, Farxiga, Glyxambi, Invokamet, Invokana, Janumet, Januvia, Jardiance, ketoacidosis, SGLT2 inhibitors, Xigduo XR
Posted in HO&P Legal Blog, Januvia and Janumet, Pharmaceutical Liability |